Lodoxamide
Chemical compound / From Wikipedia, the free encyclopedia
Lodoxamide is an antiallergic pharmaceutical drug. It is marketed under the tradename Alomide in the UK. Like cromoglicic acid it acts as a mast cell stabilizer.[1] In 2014 lodoxamide and bufrolin were found to be potent agonists at the G protein-coupled receptor 35, an orphan receptor believed to play a role in inflammatory processes, pain and the development of stomach cancer.[2]
Quick Facts Names, Identifiers ...
Names | |
---|---|
Preferred IUPAC name
N,N′-(2-Chloro-5-cyano-1,3-phenylene)dioxamic acid | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C11H6ClN3O6 | |
Molar mass | 311.63 g·mol−1 |
Pharmacology | |
S01GX05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Close